Novavax Inc (NVAX)

EBITDA

-$42.93M

Quarterly · Period ending: · USD

NVAX logo

NVAX EBITDA

Latest reported-$42.93M
NVAX Quarterly EBITDA (-$1.00M → -$42.93M)
High-resolution chart · PNG

NVAX ebitda history

Quarterly · USD. Dates are reporting period ends; fiscal years can differ from calendar years.

Novavax Inc EBITDA — Quarterly (USD)
Period endingEBITDA (USD)
-747,000
-1,369,000
-4,799,000
-3,273,000
-2,723,000
-1,353,000
-1,000,000
-1,600,000
-800,000
-800,000
-1,600,000
-1,200,000
-1,300,000
-800,000
-1,000,000
-1,100,000
-1,300,000
-1,000,000
-1,700,000
-900,000
-1,200,000
-1,000,000
Data is provided for informational purposes only and does not constitute investment advice. Past performance is not indicative of future results.